News & Articles

Dr. Masato Nakagawa to discuss induced pluripotent stem cells for regenerative research

Five color, high-performance immunohistochemistry multiplexing solution to advance biomarker studies

Team heading to San Diego, USA, to interview leading neuroscientists and report on the newest technologies

AMSBIO announces the launch of a new range of circulating tumor DNA (ctDNA) reference standards for cancer disease management research

Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance

Citrullinated histone 3 found to be associated with increased risk of thrombosis and inflammation

Learn about the different approaches that scientists are taking towards precision medicine

We bring you insights, tips and knowledge from 11 experts as they tackle biomarker research using diverse methods

Discover the nano-LC technology enabling lipidomic research

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

The findings could help clinicians decide the best course and delivery of treatment for cancer patients

Breakthrough research of faecal metabolites could lead to personalized obesity treatments within a decade

The immunoassay is the market’s first validated high-performance multiplex screening panel

The test will expand the range of diagnostic options available to guide the treatment of Plasmodium vivax

Boosting T cell memory may result in long-lasting and effective responses for patients treated with checkpoint blockade immunotherapies

CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers